Multiple system atrophy: pathogenic mechanisms and biomarkers

Area of Science:

• Neuroscience
• Pathology
• Molecular Biology

Background:

• Multiple system atrophy (MSA) is a rare proteinopathy characterized by alpha-synuclein (αSyn) accumulation.
• Unlike other α-synucleinopathies, MSA pathology primarily affects oligodendroglia, not neurons, impacting multiple brain and nervous system areas.

Purpose of the Study:

• To elucidate the pathogenesis of MSA, focusing on the role of aberrant αSyn accumulation in oligodendroglia.
• To understand the molecular mechanisms leading to glial cytoplasmic inclusions and subsequent cell dysfunction.
• To highlight the need for diagnostic biomarkers and effective treatments for MSA.

Main Methods:

• Review of existing literature and animal models to understand MSA's molecular changes.
• Analysis of the pathological process involving p25α protein relocation and αSyn accumulation.
• Investigation of cellular dysfunctions including proteasomal, mitochondrial, and lipid transport issues.

Main Results:

• Aberrant αSyn accumulation in oligodendroglia, preceded by p25α relocation, forms glial cytoplasmic inclusions, causing cell demise.
• Dysfunctions in proteasomal activity, mitochondria, lipid transport, oxidative stress, and neuroinflammation contribute to neurodegeneration.
• Prion-like transfer of toxic αSyn species and neuronal pathway involvement lead to multi-system degeneration.

Conclusions:

• MSA is a unique oligodendroglio-neuronopathy driven by αSyn pathology within oligodendroglia.
• The complex interplay of cellular dysfunctions results in a characteristic neurodegenerative pattern.
• Urgent multidisciplinary research is required for diagnostic biomarkers and therapeutic strategies for MSA.